J. Yu, M. Lu
chromatography (300 mesh). The spectra are presented in the Electronic Supple-
mentary Material.
3
-Methyl-4-oxa-5-azahomoadamantane is a known compound, prepared by the
1
literature procedure [51, 52] as shown in Scheme 3. H NMR (500 MHz, CDCl ): d
3
(
ppm) 4.68 (br s, 1H), 3.58 (s, 1H), 2.07–1.97 (m, 2H), 1.95–1.68 (m, 8H),
1
3
1
.61–1.47 (m, 2H), 1.23 (s, 3H); C NMR (125.72 MHz, CDCl ): d (ppm) 80.7,
3
?
5.0, 42.0, 36.8, 34.3, 29.8, 26.3; MS m/z: 168 (M ).
5
Typical procedure for oxidative synthesis of benzimidazoles, benzoxazoles
or benzothiazoles
A mixture of 1.2 mmol o-phenylenediamine, 2-aminophenol or 2-aminothiophenol
and 1 mmol primary amine, 10 mol% FeCl , 1 mol% 3-methyl-4-oxa-5-azaho-
3
moadamantane, 5 ml H O were mixed in a 10-ml three-necked flask, then O was
2
2
bubbled into the flask at flow rate of 20 ml/min. The reaction mixture was stirred at
100 ꢁC for several hours, and reaction progress was monitored by TLC. The final
reaction mixture was cooled to room temperature and extracted with ethyl acetate.
The organic layer was washed with brine, dried over MgSO , and concentrated
4
under reduced pressure. The residue was directly purified by column chromatog-
raphy on silica gel using hexane/ethyl acetate (7:3) as eluent to afford the pure
product.
References
1. W.A. Denny, G.W. Rewcastle, B.C. Bauley, J. Med. Chem. 33, 814 (1990)
2
. T. G u¨ ng o¨ r, A. Fouquet, J.-M. Eulon, D. Provost, M. Cazes, A. Cloarec, J. Med. Chem. 35, 4455
(1992)
3
4
5
6
7
. E. Seyhan, N. Sultan, A. Nilgun, N. Noyanalpan, Arzneim. -Forsch. 47, 410 (1997)
. L. Hu, M.L. Kully, D.W. Boykin, N. Abood, Bioorg. Med. Chem. Lett. 19, 3374 (2009)
. R. Schiffmann, A. Neugebauer, C.D. Klein, J. Med. Chem. 49, 511 (2006)
. R.P. Verma, Bioorg. Med. Chem. 13, 1059 (2005)
. K.-J. Soderlind, B. Gorodetsky, A.K. Singh, N. Bachur, G.G. Miller, J.W. Loun, Anti Cancer Drug
Des. 14, 19 (1999)
8
. D.A. Horton, G.T. Bourne, M.L. Smythe, Chem. Rev. 103, 893 (2003)
. T. Roth, M.L. Morningstar, P.L. Boyer, S.H. Hughes, R.W. Buckheit Jr, C.J. Michejda, J. Med.
Chem. 40, 4199 (1997)
9
1
1
1
1
1
1
1
1
1
1
2
0. Y. Wang, K. Sarris, D.R. Sauer, S.W. Djuric, Tetrahedron Lett. 47, 4823 (2006)
1. W. Huang, R.M. Scarborough, Tetrahedron Lett. 40, 2665 (1999)
2. Y.-C. Chi, C.-M. Sun, Synlett, 2000, p. 591
3. D. Kumar, M.R. Jacob, M.B. Reynolds, S.M. Kerwin, Bioorg. Med. Chem. 10, 3997 (2002)
4. B. Gong, F. Hong, C. Kohm, L. Bonham, P. Klein, Bioorg. Med. Chem. Lett. 14, 1455 (2004)
5. S.-T. Huang, I.-J. Hsei, C. Chen, Bioorg. Med. Chem. 14, 6106 (2006)
6. D.W. Dunwell, D. Evans, C.E. Smith, W.R.N. Williamson, J. Med. Chem. 18, 692 (1975)
7. I.B. Dzvinchuk, A.V. Vypirailenko, M.O. Lozinskii, Russ. J. Org. Chem. 34, 685 (1998)
8. E. Barni, P.J. Savarino, J. Heterocycl. Chem. 16, 1583 (1979)
9. J.B. Hendrickson, M.S. Hussoin, J. Org. Chem. 52, 4137 (1987)
0. A.W. White, R. Almassy, A.H. Calvert, N.J. Curtin, R.J. Griffin, Z. Hostomsky, K. Maegley, D.R.
Newell, S. Srinivasan, B.T. Golding, J. Med. Chem. 43, 4084 (2000)
21. B. Biasotti, S. Dallavalle, L. Merlini, C. Farina, S. Gagliardi, C. Parini, P. Belfiore, Bioorg. Med.
Chem. 11, 2247 (2003)
1
23